NRx Pharmaceuticals Closes $11 Million Unsecured Debt Financing
RADNOR, Pa., Nov. 7, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals' or the 'Company'), a clinical-stage CNS ...
Stay updated with breaking news from Complete Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RADNOR, Pa., Nov. 7, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals' or the 'Company'), a clinical-stage CNS ...
– Preliminary positive safety and efficacy data from second Phase 1 AML study supports plans to explore a Phase 1/2 of Annamycin in combination with Cytarabine...
Inhaled Niclosamide Demonstrates Potent Activity Against Omicron Variant Dosing of Inhaled Niclosamide Estimated to Produce Concentrations in Excess of...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Message : Required fields Yamana Gold Reports Significant Progress on Phase 2 Expansion at Jacobina and Strong Exploration Results for the Operation; Costs to Complete Phase 2 Significantly Reduced Compared to Original Estimate; Phase 3 Evaluation Advancing Download a PDF of detailed drill hole results for Jacobina TORONTO, July 29, 2021 (GLOBE NEWSWIRE) -- YAMANA GOLD INC. (TSX:YRI; NYSE:AUY; LSE:AUY) ('Yamana' or 'the Company') today reported significant progress on the Phase 2 expansion of the Jacobina mine to increase throughput to 8,500 tonnes per day and raise production to 230,00...